With renewed ambition, the MPCC is placing doctors at the heart of its work and strengthening dialogue with its members and cycling’s governing bodies.
Meeting for its General Assembly in Paris on 21 October, the MPCC reflected on a year of change and set out a clear priority for the future: let’s talk to turn open dialogue into meaningful action.
A doctors’ meeting in a new format
In September, in Seville, on a rest day of the Vuelta, team doctors, on site and remotely, met at the MPCC board’s initiative, led by its lead doctor, Dr Pierre Lebreton. Only doctors attended, so that they could speak freely and discuss their concerns. These concerns were then summarised and shared with the board, in order for them to determine the next steps.
These doctors’ meetings will be far more frequent in 2027. Their purpose will be to inform the Board’s decisions, and in particular the topics to be discussed with the governing bodies.
Not letting the grey area poison the sport
The aim is clear: to find ways to strengthen cycling’s credibility in a context where the grey areas are too numerous and too vast. Last December, the MPCC called on the UCI to introduce firm rules to stop the escalation of medicalisation and we will continue along that line. What is neither banned nor approved fuels suspicion, and the public cannot make sense of these situations, which damage the image of cycling.
With the input of its members, and of its Board in particular, and relying on the expertise of its doctors, the MPCC intends to remain in its role as an alarm-raiser, a role that has been essential in the past in obtaining major progress in the fight against doping from the governing bodies.
A direct dialogue with the UCI and the ITA
For the first time, the UCI Medical Director, Dr Xavier Bigard, attended our General Assembly and answered our members’ many questions. Olivier Banuls, Head of Testing at the International Testing Agency (ITA), also honoured us with his presence.
Their participation symbolises the value of exchange and dialogue. Where the MPCC once waved flags and sounded the alarm, it now also wants to build a two-way contribution.
A renewed Board, more doctors around the table
The Board welcomes Raphaël Jeune (Cofidis) and Dr Rory Nolan (Uno-X Mobility). Sébastien Hinault (Cofidis) steps down. The Board is now made up as follows:
- Emily BRAMMEIER (PicNic-PostNL)
- Patrick DELCAMBRE (Cofidis)
- Raphaël JEUNE (Cofidis)
- Roger LEGEAY
- Marc MADIOT (Groupama-FDJ United)
- Dr Jean-Reynald MILLOT (Saint-Michel – Auber 93)
- Dr Rory NOLAN (Uno-X Mobility)
- Philippe SENMARTIN
- Iwan SPEKENBRINK (PicNic-PostNL)
2027: Making every voice heard
The MPCC is committed to strengthening collaboration across professional cycling, creating more opportunities for open dialogue on the challenges facing the sport’s credibility.
At the heart of this approach is the belief that meaningful progress comes from bringing different perspectives together, encouraging constructive debate and turning shared concerns into practical recommendations.
In 2027, the MPCC will further develop its doctors’ working group, with a minimum of four meetings planned throughout the year. The initiative aims to give medical professionals a stronger voice in discussions around rider health, anti-doping and emerging practices, while ensuring their recommendations reach the relevant governing bodies.
The MPCC encourages teams, organisers, federations, sponsors, agents, riders and staff to play an active role in shaping the movement’s future.
To existing members, the message is clear: your involvement matters. We encourage you to contribute your ideas, raise concerns and take an active part in the discussions that will guide our work.
To former members and those who have not yet joined, our door remains open. We welcome the opportunity to reconnect, exchange perspectives and work together towards our shared ambition of a cleaner, healthier and more credible sport.
The MPCC believes that by bringing more voices to the table and strengthening its dialogue with cycling’s governing bodies, it can continue to be an important force for positive change.